MMWR. Recommendations and Reports:
December 16, 2005 / 54(RR15);49-55
Eurosurveillance
Impact Factor 5.7
June 2015
www.eurosurveillance.org
Featuring a series of articles on HIV and STI epidemiology, prevention and<.../span> control among MSM in Europe
more
ECDC Technical Report
In line with ECDC’s recommendations provided in the ’Risk Assessment of HTLV-1/2 transmission by tissue/cell transplantation’ dated 14 March 2012, this Directive replaces the term ‘incidence’ with ‘prevalence’ in the description of endemic areas of HTLV-1/2 <...span class="attribute-to-highlight medbox">infection. According to the new requirements ‘HTLV-1 antibody testing must be performed for donors living in, or originating from high-prevalence areas or with sexual partners originating from those areas or where the donor’s parents originate from those areas’ and this applies to both donors of non-reproductive tissues and cells and reproductive cells.
ECDC contracted experts from the Institut Pasteur in Paris to systematically review the published evidence on the distribution of HTLV-1 infection prevalence throughout the world and to identify high-prevalence countries and areas.
more
AIDSTAR-One | CASE STUDY SERIES November 2012
PLOS Medicine | https://doi.org/10.1371/journal.pmed.1002514 March 1, 2018
2018 monitoring report: current status and strategic priorities
The report sets out the status of women’s, children’s and adolescents’ health, ...and on health systems and social and environmental determinants. Regional dashboards on 16 key indicators highlight where progress is being made or lagging. There is progress overall, but not at the level required to achieve the 2030 goals. There are some areas where progress has stalled or is reversing, namely neonatal mortality, gender inequalities and health in humanitarian settings.
more
World Aids Day, 1. December 2018
Commemorating 30 Years
Accessed: 05.10.2019
With focus on creating linkages between social cash transfer programmes and HIV services
Accessed: 21.08.2019
July 2021. This publication brings together important clinical and programmatic updates produced by WHO since 2016 and provides comprehensive, evidence-informed recommendations ...e-to-highlight medbox">and good practice statements within a public health, rights-based and person-centred approach.
These guidelines bring in the most recent guidance on HIV testing strategies - the entry point for HIV prevention and treatment - and include comprehensive guidance on infant diagnosis. Key recommendations are presented on rapid antiretroviral therapy (ART) initiation and the use of dolutegravir. Updated recommendations are included on the timing of ART for people with TB, and the use of point-of-care technologies for treatment monitoring.
more
Putting Asia’s HIV response back on track
MSF International AIDS Working Group